中国比较医学杂志2024,Vol.34Issue(7) :110-120.DOI:10.3969/j.issn.1671-7856.2024.07.013

CAV1在消化道肿瘤中的研究进展

Advances in the study of CAV1 in digestive tract tumors

吴志航 唐明政 李晓凤 荣耀 崔岩 潘海邦
中国比较医学杂志2024,Vol.34Issue(7) :110-120.DOI:10.3969/j.issn.1671-7856.2024.07.013

CAV1在消化道肿瘤中的研究进展

Advances in the study of CAV1 in digestive tract tumors

吴志航 1唐明政 1李晓凤 1荣耀 1崔岩 1潘海邦1
扫码查看

作者信息

  • 1. 甘肃中医药大学第一临床医学院,甘肃省中药新产品创制工程实验室,甘肃省中医方药挖掘与创新转化重点实验室,兰州 730000
  • 折叠

摘要

消化道肿瘤是目前全球最常见的癌症之一,包括食管癌、胃癌、肝癌、胰腺癌和结直肠癌等,其预后不佳,治疗方法仍需进一步改进.小窝蛋白-1(caveolin-1,CAV1)在消化道肿瘤中具有双重调节作用,既是肿瘤抑制因子又是致癌因子.CAV1对消化道肿瘤的细胞增殖、侵袭、转移、血管生成和药物耐受性等方面具有重要作用,调节CAV1蛋白及其相关信号通路可能成为治疗消化道肿瘤的策略之一.因此,本综述就CAV1的结构、功能、表达调控以及调节消化道肿瘤上皮-间充质转换(epithelial-mesenchymal transition,EMT)及其耐药性等方面分析CAV1与消化道肿瘤的关系,以期为临床消化道肿瘤的诊疗提供新的思路.

Abstract

Digestive tract tumors are currently one of the most common types of cancer,including esophageal cancer,gastric cancer,hepatocellular carcinoma,pancreatic cancer,and colorectal cancer.Their prognoses are poor and the treatments require further improvement.Caveolin-1(CAV1)has a dual regulatory effect on digestive tract tumors as a tumor suppressor and cancer promoter.CAV 1 plays a major role in cell proliferation,invasion,metastasis,angiogenesis,and drug tolerance of digestive tract tumors.The regulation of CAV1 protein and its related signaling pathways may be a strategy for the treatment of digestive tract tumors.This review analyzes the relationship between CAV 1 and digestive tract tumors in terms of structure,function,expression regulation,regulation of epithelial-mesenchymal transition,and drug resistance in digestive tract tumors to provide new ideas for the diagnosis and treatment of digestive tract tumors.

关键词

CAV1/消化道肿瘤/EMT/耐药

Key words

CAV 1/digestive tract tumor/EMT/drug resistance

引用本文复制引用

基金项目

国家自然科学基金(81860850)

甘肃省高等学校创新基金(2023A-076)

出版年

2024
中国比较医学杂志
中国实验动物学会,中国医学科学院医学实验动物研究所

中国比较医学杂志

CSTPCD北大核心
影响因子:0.473
ISSN:1671-7856
段落导航相关论文